Skip Nav

Clinical Guidelines Portal

Home > Guidelines > Perinatal Guidelines > Special Considerations Regarding the Use of Antiretroviral Drugs by HIV-Infected Pregnant Women and Their Infants
Text Size

Updated Perinatal Guideline

Updates were made to the Perinatal Guideline on January 22, 2013 and January 29, 2012. For an explanation of the updates, please see the correction notice.

Search Search Help

Guideline Search

Type your search term(s) in the text box. Users can only search one guideline at a time. To search for an exact phrase, use quotation marks (i.e. "what to start"). To narrow your search, add additional relevant terms. If you are not finding what you need, try searching similar terms (i.e. perinatal OR pregnancy) to broaden your search.Close

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Special Considerations Regarding the Use of Antiretroviral Drugs by HIV-Infected Pregnant Women and Their Infants

Printer-Friendly Files

Overview
 Pharmacokinetic Changes
 Teratogenicity
 Combination Antiretroviral Drug Regimens and Pregnancy Outcome
 Nevirapine and Hepatic/Rash Toxicity
 Nucleoside Reverse Transcriptase Inhibitor Drugs and Mitochondrial Toxicity
 Protease Inhibitor Therapy and Hyperglycemia